yourstate.us
32 CFR 147.10

§ 147.10 Guideline H—Drug involvement.

United States · 32 CFR — National Defense · Status: effective

Get this as JSONEmbed this
Cite this
Citation
32 CFR 147.10, § 147.10 Guideline H—Drug involvement, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/145371
Permanent ID
ys:prov:145371@1
SHA-256
9b27e824b86bec9a022a31fab6c0f557123ceb3a1cda75d5df1e225ad4989b1d

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) The concern. (1) Improper or illegal involvement with drugs raises questions regarding an individual's willingness or ability to protect classified information. Drug abuse or dependence may impair social or occupational functioning, increasing the risk of an unauthorized disclosure of classified information. (2) Drugs are defined as mood and behavior altering substances, and include: (i) Drugs, materials, and other chemical compounds identified and listed in the Controlled Substances Act of 1970, as amended (e.g., marijuana or cannabis, depressants, narcotics, stimulants, and hallucinogens), (ii) Inhalants and other similar substances. (3) Drug abuse is the illegal use of a drug or use of a legal drug in a manner that deviates from approved medical direction. (b) Conditions that could raise a security concern and may be disqualifying include: (1) Any drug abuse (see above definition); (2) Illegal drug possession, including cultivation, processing, manufacture, purchase, sale, or distribution; (3) Diagnosis by a credentialed medical professional (e.g., physician, clinical psychologist, or psychiatrist) of drug abuse or drug dependence; (4) Evaluation of drug abuse or drug dependence by a licensed clinical social worker who is a staff member of a recognized drug treatment program; (5) Failure to successfully complete a drug treatment program prescribed by a credentialed medical professional. Recent drug involvement, especially following the granting of a security clearance, or an expressed intent not to discontinue use, will almost invariably result in an unfavorable determination. (c) Conditions that could mitigate security concerns include: (1) The drug involvement was not recent; (2) The drug involvement was an isolated or aberration event; (3) A demonstrated intent not to abuse any drugs in the future; (4) Satisfactory completion of a prescribed drug treatment program, including rehabilitation and aftercare requirements, without recurrence of abuse, and a favorable prognosis by a credentialed medical professional.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.